| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Chief Scientific Officer | Non-Qualified Stock Option (right to buy) | 123,559 | 05 Feb 2025 | Direct | ||
| PIERIS PHARMACEUTICALS, INC. | Chief Scientific Officer | Incentive Stock Option (right to buy) | 5,373 | 05 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVLA | PALVELLA THERAPEUTICS, INC. | 05 Feb 2025 | 2 | $0 | 4 | Chief Scientific Officer | 07 Feb 2025, 16:30 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 05 Feb 2025 | 2 | $0 | 4 | CFO and Treasurer | 07 Feb 2025, 16:30 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 05 Feb 2025 | 1 | $0 | 4 | President and CEO, Director | 07 Feb 2025, 16:29 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 05 Feb 2025 | 2 | $0 | 4 | Chief Operating Officer | 07 Feb 2025, 16:29 |